1. Narimani, Manizheh, Sharifi, Mohammadreza, Hakhamaneshi, Mohammad Saeed, Hejazi, Seyed Hossein, Jalili, Ali. 2019. BIRC5 Gene Disruption via CRISPR/Cas9n Platform Suppress Acute Myelocytic Leukemia Progression. In Iranian biomedical journal, 23, 369-78. doi:. https://pubmed.ncbi.nlm.nih.gov/31104397/
2. Hattori, Etsuko Yamamoto, Masuda, Tatsuya, Mineharu, Yohei, Arakawa, Yoshiki, Kamikubo, Yasuhiko. 2022. A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice. In Communications biology, 5, 939. doi:10.1038/s42003-022-03917-5. https://pubmed.ncbi.nlm.nih.gov/36085167/
3. Jiang, Xiulin, Shi, Yulin, Chen, Xi, Li, Lihua, Pu, Jun. 2022. The N6-Methylandenosine-Related Gene BIRC5 as a Prognostic Biomarker Correlated With Cell Migration and Immune Cell Infiltrates in Low Grade Glioma. In Frontiers in molecular biosciences, 9, 773662. doi:10.3389/fmolb.2022.773662. https://pubmed.ncbi.nlm.nih.gov/35309512/
4. Narimani, Manizheh, Sharifi, Mohammadreza, Jalili, Ali. 2019. Knockout Of BIRC5 Gene By CRISPR/Cas9 Induces Apoptosis And Inhibits Cell Proliferation In Leukemic Cell Lines, HL60 And KG1. In Blood and lymphatic cancer : targets and therapy, 9, 53-61. doi:10.2147/BLCTT.S230383. https://pubmed.ncbi.nlm.nih.gov/31819702/
5. Xu, Ming, Hu, Xianyu, Zhang, Meng, Ge, Yating. 2019. What is the impact of BIRC5 gene polymorphisms on urinary cancer susceptibility? Evidence from 9348 subjects. In Gene, 733, 144268. doi:10.1016/j.gene.2019.144268. https://pubmed.ncbi.nlm.nih.gov/31809840/
智鼠故事 
